Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex

NeuroReport

Volumn 17, Issue 4, 2006, Pages 413-416

  Mihara, Masahito ^a   Hattori, Noriaki ^a   Abe, Kazuo ^a   Sakoda, Saburo ^a   Sawada, Tohru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Corticobasal degeneration; Frontotemporal dementia; Magnetic resonance spectroscopy; Myoinositol; N acetylaspartate; Pick's disease; Progressive supranuclear palsy

Indexed keywords

CREATINE PHOSPHATE; CREATININE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MEASUREMENT; METABOLIC BALANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; PARIETAL LOBE; PATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTRUM; STANDARD; VOLUNTEER; WHITE MATTER; BRAIN CORTEX; BRAIN MAPPING; DEMENTIA; DOWN REGULATION; ENERGY METABOLISM; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN MAPPING; CEREBRAL CORTEX; CREATINE; DEMENTIA; DOWN-REGULATION; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARIETAL LOBE; PICK DISEASE OF THE BRAIN;

EID: 33646679630     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000203353.52622.05     Document Type: Article

References (25)

1. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997; 203:829-836.
2. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. AJNR Am J Neuroradiol 2003; 24:843-849.
3. Firbank MJ, Harrison RM, O'Brien JT. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Ceriatr Cogn Disord 2002; 14:64-76.
4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
5. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58:1803-1809.
6. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
7. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1-9.
8. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128:1996-2005.
9. Kertesz A, Davidson W, Munoz DG. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement Geriatr Cogn Disord 1999; 10 (Suppl 1):46-49.
10. Ritchie CW, Ames D, Clayton T, Lai R. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry 2004; 12: 358-369.
11. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, et al. 1H MR spectroscopy in common dementias. Neurology 2004; 63:1393-1398.
12. Abe K, Terakawa H, Takanashi M, Watanabe Y, Tanaka H, Fujita N, et al. Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 2000; 52:589-595.
13. Kizu O, Yamada K, Ito H, Nishimura T. Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology 2004; 46:277-281.
14. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48:119-125.
15. Wechsler D. Manual for the Wechsler Adult Intelligence Scale: revised. The Psychological Corporation: Cleveland; 1981.
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Resort Med 1993; 30:672-679.
17. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. NeuroReport 1991; 2:131-134.
18. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42:85-94.
19. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 1999;10:149-162.
20. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20:1619-1627.
21. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R. In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 1997; 68:161-172.
22. Schofield E, Kersaitis C, Shepherd CE, Kril JJ, Halliday GM. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: taupositive glia differentiate these disorders. Brain 2003; 126:827-840.
23. Hattori N, Abe K, Sakoda S, Sawada T. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. NeuroReport 2002; 13:183-186.
24. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989.
25. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45:765-769.